The role of higher coformer stoichiometry ratio in pharmaceutical cocrystals for improving their solid-state properties: The cocrystals of progesterone and 4-hydroxybenzoic acid

被引:27
作者
Samipillai, Marivel [1 ]
Rohani, Sohrab [1 ]
机构
[1] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Solubility; Crystal structure; Growth from solutions; Organic compoundst; HYDROGEN-BOND; SUPRAMOLECULAR SYNTHONS; SOLUBILITY; INDOMETHACIN; NICOTINAMIDE; STABILITY;
D O I
10.1016/j.jcrysgro.2018.10.050
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
Progesterone (PROG) is a naturally occurring and poorly water soluble steroid hormone that belongs to the broad category of progestins. In this study, the poor aqueous solubility of PROG had been addressed through its cocrystallization with suitable coformer, 4-hydroxybenzoic acid (4-HBA). Investigation of the role of higher coformer concentration in cocrystals to enhance the aqueous solubility of PROG was the main objective of this study. For this purpose, cocrystals of PROG and 4-HBA were prepared in different stoichimetry ratios such as 1: 1_A, 2: 1 and 1: 2 of PROG to 4-HBA,. All cocrystals were systematically characterized through X-ray powder diffraction, DSC, H-1 NMR, IR and optical microscopy techniques. The crystal structure for 2: 1 and 1: 2 cocrystals was obtained from single crystal X-ray diffraction and analysed. A mixture of kinetic forms (named as 1: 1_B) was obtained with grinding of equimolar mixture of PROG and 4-HBA, which produced thermodynamically stable 1: 1_A cocrystal upon recrystallization. Cocrystals were characterized with single crystal X-ray diffraction, XRPD, DSC and FTIR. The equilibrium solubility measurements for the cocrystals were carried out in water and ethanol where the cocrystal forms exhibited enhanced solubility profiles than PROG.
引用
收藏
页码:270 / 282
页数:13
相关论文
共 50 条
[31]   A rapid thermal method for cocrystal screening [J].
Lu, Enxian ;
Rodriguez-Hornedo, Nair ;
Suryanarayanan, Raj .
CRYSTENGCOMM, 2008, 10 (06) :665-668
[32]   Preparation and Characterization of Theophylline-Nicotinamide Cocrystal [J].
Lu, Jie ;
Rohani, Sohrab .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2009, 13 (06) :1269-1275
[33]   THERMODYNAMIC RELATIONSHIP BETWEEN ALPHA-FORMS AND BETA-FORMS OF CRYSTALLINE PROGESTERONE [J].
MURAMATSU, M ;
IWAHASHI, M ;
TAKEUCHI, U .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (02) :175-177
[34]   Pharmaceutical cocrystals: An overview [J].
Qiao, Ning ;
Li, Mingzhong ;
Schlindwein, Walkiria ;
Malek, Nazneen ;
Davies, Angela ;
Trappitt, Gary .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 419 (1-2) :1-11
[35]   Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies [J].
Ross, S. A. ;
Lamprou, D. A. ;
Douroumis, D. .
CHEMICAL COMMUNICATIONS, 2016, 52 (57) :8772-8786
[36]   Hydrogen Bond Synthons in the Interplay of Solubility and Membrane Permeability/Diffusion in Variable Stoichiometry Drug Cocrystals [J].
Saikia, Basanta ;
Bora, Pranita ;
Khatioda, Rajiv ;
Sarma, Bipul .
CRYSTAL GROWTH & DESIGN, 2015, 15 (11) :5593-5603
[37]   Polymorphism of Progesterone: A New Approach for the Formation of Form II and the Relative Stabilities of Form I and Form II [J].
Sarkar, Anindita ;
Ragab, Doaa ;
Rohani, Sohrab .
CRYSTAL GROWTH & DESIGN, 2014, 14 (09) :4574-4582
[38]   Pharmaceutical Cocrystals and Their Physicochemical Properties [J].
Schultheiss, Nate ;
Newman, Ann .
CRYSTAL GROWTH & DESIGN, 2009, 9 (06) :2950-2967
[39]   The role of cocrystals in pharmaceutical science [J].
Shan, Ning ;
Zaworotko, Michael J. .
DRUG DISCOVERY TODAY, 2008, 13 (9-10) :440-446
[40]  
Sheldrick G.-M., 2014, PROGRAM XRAY CRYSTAL